Loading clinical trials...
Loading clinical trials...
A Randomised, Evaluator-Blinded, Two-Arm Study To Evaluate The Safety And Efficacy of a Novel Microneedle and Laser-Based Medical Device For The Treatment of Androgenetic Alopecia in Adult Males
The purpose of this 24-week study is to see if the SAGA-001 device is safe and effective at helping people with male pattern hair loss. Two different device configurations are being explored as part of this study. Device A has novel microneedles, lasers, and additional metal microneedles, while Device B only has novel microneedles and lasers. Participants will receive 12 treatments with either Device A or Device B over the course of 24 weeks. Treatments will be performed on-site every two weeks.
Participants will have the medical tests or procedures described below: * Subjects will be asked about their previous medical history and current medications. * Brief physical examinations will be performed, including a visual inspection of the scalp. * Questions about medical history (including previous and current medication use) will be asked. * Two types of photos will be taken: 1) "global photos", which are general photos of the subject's scalp, and 2) "macro photos", which are close-up photos of a part of the subject's scalp. * Questions about treatment-related issues or unpleasantness will be asked. * Subjects will be asked to rate the improvement they see in their photos. * Subjects will be asked to rate their satisfaction with the treatment. Participants will also be asked to record changes in medications, changes in medical treatments, and major life changes (such as major dietary changes, exercise changes, changes in life stressors, etc.) in a diary for the duration of treatment. They should also make note of any suspected side effects or issues they believe are related to the treatment.
Age
22 - 55 years
Sex
MALE
Healthy Volunteers
No
Ankara Bilkent Şehir Hastanesi Dermatoloji Klini
Ankara, Turkey (Türkiye)
İstanbul Üniversitesi Cerrahpaşa Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü Deri ve Zührevi Hastalıklar Ana Bilim Dalı Kocamustafa Paşa
Istanbul, Turkey (Türkiye)
Start Date
June 1, 2023
Primary Completion Date
August 30, 2024
Completion Date
October 24, 2024
Last Updated
May 30, 2025
82
ACTUAL participants
SAGA-001 (A)
DEVICE
SAGA-001 (B)
DEVICE
Lead Sponsor
StimuSIL
Collaborators
NCT07012486
NCT07011485
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07248410